GBMA chief steps down

Departing GBMA chief executive lauded for strategic foresight and unwavering commitment to improving medicines affordability  After eight years at the helm of the Generic and Biosimilar Medicines Association (GBMA), Marnie Peterson is stepping down as its chief executive.   In a statement released on Friday (29 May 2026), the organisation’s independent chair, Professor Jane Halton, praised Peterson’s contribution to